-
Mashup Score: 1ASH 2021: Treating Relapsed/Refractory Multiple Myeloma - 2 year(s) ago
Dr. Krina Patel explains how to make informed treatment decisions for patients with relapsed/refractory multiple myeloma and other updates from ASH 2021.
Source: Patient PowerCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0New Treatments Pending for Uveal Melanoma - 2 year(s) ago
There are several treatments for uveal melanoma pending FDA approval, including a promising new immunotherapy. Read more.
Source: Patient PowerCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Saving a Life With Stem Cells - 2 year(s) ago
Myelofibrosis patient Beatrice Larroque meets with her stem cell donor and explains how his selfless act saved her life.
Source: Patient PowerCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Can a Blood Test Detect Cancer in the Body? - 2 year(s) ago
A new screening blood test isn’t ready for prime time but hints at the future of blood tests detecting cancer. Learn more.
Source: Patient PowerCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Evening with the Docs — Your Questions Answered - 2 year(s) ago
Steven Green, MD, answers questions from the live event Evening with the Docs: Roswell Park.
Source: Patient PowerCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Answers Now: Living with Polycythemia Vera (PV) - 2 year(s) ago
Want to hear the latest news for your cancer type? Patient Power’s events are free and feature cancer experts sharing information for people living with cancer.
Source: Patient PowerCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Pam Kohl discusses how palliative care is helpful at any point in the treatment journey and can dramatically improve quality of life.
Source: Patient PowerCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4Ibrutinib Plus Ublituximab May Lead to Improved CLL Outcomes - 2 year(s) ago
A recent study found that ibrutinib plus ublituximab led to improved outcomes, including higher rates of progression-free survival, for CLL patients.
Source: Patient PowerCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 07 Tips for Safer Travel While COVID Restrictions Ease - 2 year(s) ago
Discover how people living with cancer can both make travel plans and protect themselves from COVID-19.
Source: Patient PowerCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Take These 7 Precautions to Protect Yourself While Traveling While much of the world is moving on from #COVIDrestrictions, people with cancer still must navigate their travel plans carefully. Here are 7 tips from an expert on staying safe: https://t.co/U8tBkFvvVq #covidtravel https://t.co/JUQSoX79lr
-
-
Mashup Score: 0Systemic Mastocytosis Life Expectancy - 2 year(s) ago
Learn the life expectancy rates for patients with systemic mastocytosis grouped by type.
Source: Patient PowerCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
Treating Relapsed/Refractory #MultipleMyeloma @DrKrinaPatel from @MDAndersonNews explains the future of CAR T-cell therapy and how it may affect the role of transplants, and promising data on bispecific antibodies: https://t.co/bxIYrGMlY2 #mmsm #oncotwitter https://t.co/aJmKBSnVgc